WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+11.55%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$8.41B
AUM Growth
+$1.34B
(+19%)
Cap. Flow
+$970M
Cap. Flow
% of AUM
11.53%
Top 10 Holdings %
Top 10 Hldgs %
15.67%
Holding
835
New
215
Increased
181
Reduced
162
Closed
219
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
+$126M |
| 2 |
Cencora
COR
|
+$118M |
| 3 |
HES
Hess
HES
|
+$114M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$112M |
| 5 |
Microsoft
MSFT
|
+$110M |
Top Sells
| 1 |
Keysight
KEYS
|
+$109M |
| 2 |
Baxter International
BAX
|
+$108M |
| 3 |
Analog Devices
ADI
|
+$105M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$76.6M |
| 5 |
Booking.com
BKNG
|
+$58.2M |
Sector Composition
| 1 | Healthcare | 37.65% |
| 2 | Technology | 28.08% |
| 3 | Industrials | 9.46% |
| 4 | Energy | 7.76% |
| 5 | Consumer Discretionary | 5.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Capri Holdings
CPRI
$2.44B
| $2.03M | 0.02% |
56,682
-20,384
| -26% | -$732K |
|
427
TransDigm Group
TDG
$72.9B
| $2.02M | 0.02% |
2,257
-44,948
| -95% | -$40.2M |
|
428
Nuvalent
NUVL
$5.83B
| $2.02M | 0.02% |
+47,850
| New | +$2.02M |
|
429
Vir Biotechnology
VIR
$721M
| $2M | 0.02% |
+81,386
| New | +$2M |
|
430
Fulcrum Therapeutics
FULC
$393M
| $1.97M | 0.02% |
+596,695
| New | +$1.97M |
|
431
MannKind Corp
MNKD
$1.71B
| $1.96M | 0.02% |
482,126
-1,352,154
| -74% | -$5.5M |
|
432
MacroGenics
MGNX
$111M
| $1.95M | 0.02% |
+364,700
| New | +$1.95M |
|
433
Progress Software
PRGS
$1.86B
| $1.93M | 0.02% |
+33,277
| New | +$1.93M |
|
434
ManpowerGroup
MAN
$1.78B
| $1.89M | 0.02% |
+23,785
| New | +$1.89M |
|
435
Celsius Holdings
CELH
$14.3B
| $1.88M | 0.02% |
37,875
-404,787
| -91% | -$20.1M |
|
436
Celldex Therapeutics
CLDX
$1.52B
| $1.85M | 0.02% |
54,499
-972
| -2% | -$33K |
|
437
Shutterstock
SSTK
$724M
| $1.83M | 0.02% |
37,558
+23,695
| +171% | +$1.15M |
|
|
TVRD
438
Tvardi Therapeutics, Inc. Common Stock
TVRD
$278M
| $1.79M | 0.02% |
17,538
+16,357
| +1,385% | +$1.67M |
|
|
MFM
439
MFS Municipal Income Trust
MFM
$213M
| $1.78M | 0.02% |
348,464
-266,929
| -43% | -$1.36M |
|
440
Levi Strauss
LEVI
$8.76B
| $1.78M | 0.02% |
123,020
-261,069
| -68% | -$3.77M |
|
|
JSD
441
DELISTED
NUVEEN SHORT DURATION CREDIT OPPORTUNITIES FUND
JSD
| $1.77M | 0.02% |
153,500
-25,682
| -14% | -$297K |
|
442
Krispy Kreme
DNUT
$539M
| $1.75M | 0.02% |
118,645
-183,827
| -61% | -$2.71M |
|
443
Nuveen Preferred & Income Opportunities Fund
JPC
$2.63B
| $1.73M | 0.02% |
267,151
+34,501
| +15% | +$224K |
|
444
Informatica
INFA
$7.55B
| $1.72M | 0.02% |
92,767
+75,586
| +440% | +$1.4M |
|
445
Ziff Davis
ZD
$1.58B
| $1.72M | 0.02% |
+24,480
| New | +$1.72M |
|
|
ETO
446
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
$450M
| $1.71M | 0.02% |
74,467
| – | – |
|
|
NEWR
447
DELISTED
New Relic, Inc.
NEWR
| $1.69M | 0.02% |
25,797
+17,307
| +204% | +$1.13M |
|
448
Seer Inc
SEER
$118M
| $1.67M | 0.02% |
390,547
+7,413
| +2% | +$31.7K |
|
449
Janux Therapeutics
JANX
$1.49B
| $1.63M | 0.02% |
137,300
| – | – |
|
|
OKUR
450
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$35.6M
| $1.63M | 0.02% |
+24,800
| New | +$1.63M |
|